DUBLIN, November 23, 2017 /PRNewswire/ --
The "Non-vascular Stents Market Analysis By Product [Gastrointestinal (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents), Pulmonary, Urological Stents], And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.
The global non-vascular stents market is anticipated to reach USD 1.4 billion by 2025
The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in adoption of minimally invasive surgeries across the world.
Technological advancements such as development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy(cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per requirement as they offer different features.
Due to high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.
Further Key Findings From the Study Suggest:
- The urological stents segment held a lucrative market share in 2016 owing to worldwide increase in demand for ureteral, and prostate stents, which can be attributed to the surge in number of kidney transplants, ureteroscopy, ureterorenoscopy, lithotripsy, and schistosomiasis procedures
- The gastrointestinal stents segment is expected to register highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus
- North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with high prevalence of gastrointestinal cancer in the U.S. & Canada
- Some of the key players in the market are Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL INC; Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; and Glaukos Corporation
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Non-vascular Stents Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
18.104.22.168 Growing geriatric population & prevalence of chronic and other diseases
22.214.171.124 Increasing adoption of minimally invasive surgeries
126.96.36.199 Technological developments in non-vascular stents
188.8.131.52 Rising per capita healthcare spending
3.1.2 Market restraint analysis
184.108.40.206 Complications associated with non-vascular stents
3.2 Penetration & growth prospect mapping
3.3 Non-vascular Stents - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.3.1 Market SWOT analysis, by factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's
Chapter 4 Non-vascular Stents Product Estimates & Trend Analysis
4.1 Non-vascular stents market: Product movement analysis
4.2 Gastrointestinal Stents
4.3 Pulmonary (Airway) Stents
4.4 Urological Stents
Chapter 5 Non-vascular Stents Regional Estimates & Trend Analysis, by Product
Chapter 6 Competitive Landscape
- C. R. Bard, Inc.
- Boston Scientific Corporation
- ELLA - CS, s.r.o.
- CONMED Corporation
- HOBBS MEDICAL INC
- Cook Medical
- Taewoong Medical Co., Ltd.
- Synchron Med Inc.
- Glaukos Corporation
For more information about this report visit https://www.researchandmarkets.com/research/2fw4g4/nonvascular
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets